Why technology standards are critical for Quantum-Safe Security

Safeguard Insights

February 8, 2011

Bubble Bubble, Toil and Trouble – or Not?

In the wake of bursting housing and financial bubbles, it is little wonder why there is widespread speculation throughout the venture capital and private equity…

Posted by John E. Shave III

December 21, 2010

Clarient and Avid Radiopharmaceuticals Complete Acquisitions

Earlier this quarter, we announced that partner companies Clarient (Nasdaq: CLRT) and Avid Radiopharmaceuticals had signed definitive agreements to be acquired by GE Healthcare and…

Posted by Peter J. Boni

November 8, 2010

Eli Lilly Agrees to Acquire Safeguard Scientifics Partner Company Avid Radiopharmaceuticals

For the second time in as many weeks, I am pleased to announce that a major player in the pharmaceutical industry has recognized the value…

Posted by Peter J. Boni

October 22, 2010

Partner Company Clarient (Nasdaq: CLRT) to be Acquired by GE Healthcare for $587 Million

At Safeguard Scientifics, our strategy is to provide growth capital for entrepreneurial and innovative life sciences and technology companies, build value in those companies and…

Posted by Peter J. Boni

August 27, 2010

The Current Competitive M&A Climate

As reported recently in The Wall Street Journal, companies are sitting on nearly $2 trillion of cash. As a result, shareholders are beginning to ask…

Posted by Stephen T. Zarrilli

August 16, 2010

IPOs: A Financing Event

On the heels of continued IPO activity, there has been a flurry of media coverage — both positive and negative — regarding the companies that…

Posted by Peter J. Boni

July 7, 2010

Exit Environment and Valuations

According to new research published in this month’s Journal of Business Venturing, privately held businesses that start the initial public offering (IPO) process at the…

Posted by Stephen T. Zarrilli